[조사 보고서] 세계의 액체 생검 시장 (2024-2030) : 바이오마커별 (엑소좀, CTC), 용도별 (암, 생식기), 기술별, 샘플 유형별, 임상 용도별, 최종 용도별, 제품별, 지역별

■ 영문 제목 : Liquid Biopsy Market Size, Share & Trends Analysis Report By Biomarker (Exosomes, CTC), By Application (Cancer, Reproductive Health), By Technology, By Sample Type, By Clinical Application, By End-use, By Product, By Region, And Segment Forecasts, 2024 - 2030
	■ 상품코드 : GRV24JNU066 ■ 조사/발행회사 : Grand View Research ■ 발행일 : 2023년 12월 ■ 페이지수 : 150 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (납기 : 3일) ■ 조사대상 지역 : 세계 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD5,950 ⇒환산￦8,032,500	견적의뢰/주문/질문
Multi User (5인 열람용)	USD6,950 ⇒환산￦9,382,500	견적의뢰/주문/질문
Global/corporate License (기업 열람용)	USD8,950 ⇒환산￦12,082,500	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 액체 생검 시장의 성장 및 동향 보고서
세계의 액체 생검 시장 규모는 2030년 228.8억 달러로 평가되며, 2023년부터 2030년까지 연평균 9.7%의 성장률(CAGR)로 확대될 것으로 예상됩니다. 암 유병률의 증가와 노령 인구의 증가는 시장 성장을 촉진할 것으로 예상됩니다. 또한, 질병의 조기 발견을 위한 기술적으로 진보된 장비의 사용은 시장을 이끄는 주요 요인 중 하나입니다. 또한, 비침습적 치료 절차에 대한 선호도가 높아짐에 따라 예측 기간 동안 유리한 기회를 제공 할 것입니다.

최근 몇 년 동안 암 환자 수가 크게 증가했으며 이러한 추세는 당분간 변하지 않을 것으로 예상됩니다. 생활양식의 급격한 변화로 인해 전 세계 인구가 이 질환에 노출되어 발암 요인이 발생하고 있습니다. 예를 들어, 미국 암 협회에 따르면 2022년 신규 암 환자 수는 190만 명에 달하고 60만9360명이 사망할 것으로 예상됩니다. 기업들은 임상 액체 생검 영역의 사업 확장에 주력하고 있습니다.

예를 들어, 2021년 12월 헬리오헬스(Helio Health)와 풀젠트 제네틱스(Fulgent Genetics)는 간암 조기 발견을 위한 새로운 액체 생검 검사인 헬리오리버(HelioLiver)를 출시할 것이라고 발표했습니다. 이 액체 생검 검사는 혈청 단백질 마커와 무세포 DNA 메틸화 패턴을 결합해 간암을 조기에 발견할 수 있습니다. 또한, 새로운 연구 조사가 새로운 액체 생검 기술 개발에 도움이 되고 있습니다. 예를 들어, 2022년 7월 센트럴 플로리다 대학은 폐암과 유방암의 바이오마커 식별을 통해 조기 발견을 촉진하고 병태를 쉽게 모니터링할 수 있는 새로운 액체 생검 기술 개발을 발표했습니다.

액체 생검에 대한 기업들의 관심이 높아지고 신제품 승인율이 높아지면서 시장 성장세가 더욱 가속화되고 있습니다. 또한, 최근 몇 년 동안 액체 생검 플랫폼에 대한 연구 결과들이 좋은 결과를 보여주고 있습니다. 정부 및 다양한 규제 기관도 이 기술의 급속한 발전을 위해 여러 획기적인 장치를 추진함으로써 이 분야에 관심을 보이고 있습니다. 다양한 기업의 높은 기술 채택률과 정부의 자금 지원 및 이니셔티브 지원으로 인해 향후 몇 년 동안 시장이 성장할 것으로 예상됩니다.

액체 생검 시장 보고서 하이라이트

- ctDNA 분야는 액체 생검을 이용한 암 검출의 바이오마커로 널리 사용되고 있어 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다.

- 다중 유전자 병렬 분석(NGS) 기술 분야는 연구개발 증가, 암 사례 증가, 기술 발전, 주요 기업들의 전략적 활동으로 인해 높은 성장이 예상됩니다.

- 북미는 신기술에 대한 수요 증가, 주요 플레이어의 대규모 풀, 여러 임상 검사 기관의 존재, 이 지역의 선진화된 의료 인프라로 인해 2022년 세계 시장을 지배할 것으로 예측됩니다.

- 아시아 태평양 지역은 대상 질환의 유병률 증가와 주요 플레이어의 존재로 인해 향후 상당한 성장이 예상됩니다.

■ 보고서 개요

1. 조사 방법 및 범위
2. 개요
3. 세계의 액체 생검 시장 변수, 동향, 범위
4. 세계의 액체 생검 시장 규모 : 유형별 비즈니스 분석
5. 세계의 액체 생검 시장 규모 : 바이오마커별 비즈니스 분석
6. 세계의 액체 생검 시장 규모 : 기술별 비즈니스 분석
7. 세계의 액체 생검 시장 규모 : 용도별 비즈니스 분석
8. 세계의 액체 생검 시장 규모 : 최종 용도별 비즈니스 분석
9. 세계의 액체 생검 시장 규모 : 임상 용도별 비즈니스 분석
10. 세계의 액체 생검 시장 규모 : 제품별 비즈니스 분석
11. 세계의 액체 생검 시장 규모 : 지역별 비즈니스 분석
12. 경쟁 현황

■ 보고서 목차

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation
1.1.1. Market Definitions
1.2. Objectives
1.2.1. Objective – 1
1.2.2. Objective – 2
1.2.3. Objective – 3
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Gvr’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List Of Secondary Sources
1.9. List of Abbreviations
1.10. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers
3.4.1. Increasing prevalence of cancer
3.4.2. Growing geriatric population
3.4.3. Technological advancements
3.4.4. Increasing preference for noninvasive treatment
3.5. Market Restraint Analysis
3.5.1. Patent expiry of blockbuster drugs prescribed
3.6. Business Environment Analysis
3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
3.6.2. Porter’s Five Forces Analysis
3.6.3. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
4.1. Liquid Biopsy Market: Type Movement Analysis
4.2. Blood Sample
4.2.1. Blood Sample Market, 2018 – 2030 (USD Million)
4.3. Others
4.3.1. Others Market, 2018 – 2030 (USD Million)
Chapter 5. Biomarker Business Analysis
5.1. Liquid Biopsy Market: Biomarker Movement Analysis
5.2. Circulating Tumor Cells (CTCs)
5.2.1. Circulating Tumor Cells (CTCs) Market, 2018 – 2030 (USD Million)
5.3. Circulating Tumor DNA (catena)
5.3.1. Circulating Nucleic Acids Market, 2018 – 2030 (USD Million)
5.4. Exosomes/Microvesicles
5.4.1. Exosomes/Microvesicles Market, 2018 – 2030 (USD Million)
5.5. Others
5.5.1. Others Market, 2018 – 2030 (USD Million)
Chapter 6. Technology Business Analysis
6.1. Liquid Biopsy Market: Technology Movement Analysis
6.2. Multi-gene-parallel Analysis (NGS)
6.2.1. Multi-gene-parallel Analysis (NGS) Market, 2018 – 2030 (USD Million)
6.3. Single Gene Analysis (PCR Microarrays)
6.3.1. Single Gene Analysis (PCR Microarrays) Market, 2018 – 2030 (USD Million)
Chapter 7. Application Business Analysis
7.1. Liquid Biopsy Market: Application Movement Analysis
7.2. Cancer
7.2.1. Cancer Market, 2018 – 2030 (USD Million)
7.2.1.1. Lung Cancer
7.2.1.2. Lung Cancer Market, 2018 – 2030 (USD Million)
7.2.1.3. Prostate Cancer
7.2.1.4. Prostate Cancer Market, 2018 – 2030 (USD Million)
7.2.1.5. Breast Cancer
7.2.1.6. Breast Cancer Market, 2018 – 2030 (USD Million)
7.2.1.7. Colorectal Cancer
7.2.1.8. Colorectal Cancer Market, 2018 – 2030 (USD Million)
7.2.1.9. Leukemia
7.2.1.10. Leukemia Market, 2018 – 2030 (USD Million)
7.2.1.11. Gastrointestinal Cancer
7.2.1.12. Gastrointestinal Cancer Market, 2018 – 2030 (USD Million)
7.2.1.13. Others
7.2.1.14. Others Market, 2018 – 2030 (USD Million)
7.3. Reproductive Health
7.3.1. Reproductive Health Market, 2018 – 2030 (USD Million)
7.4. Others
7.4.1. Others Market, 2018 – 2030 (USD Million)
Chapter 8. End-Use Business Analysis
8.1. Liquid Biopsy Market: End-Use Movement Analysis
8.2. Hospitals and Laboratories
8.2.1. Hospitals and Laboratories Market, 2018 – 2030 (USD Million)
8.3. Specialty Clinics
8.3.1. Specialty Clinics Market, 2018 – 2030 (USD Million)
8.4. Academic and Research Centers
8.4.1. Academic and Research Centers Market, 2018 – 2030 (USD Million)
8.5. Others
8.5.1. Others Liquid Biopsy Market, 2018 – 2030 (USD Million)
Chapter 9. Clinical Application Business Analysis
9.1. Liquid Biopsy Market: Clinical Application Movement Analysis
9.2. Therapy Selection
9.2.1. Therapy Selection Market, 2018 – 2030 (USD Million)
9.3. Treatment Monitoring
9.3.1. Treatment Monitoring Market, 2018 – 2030 (USD Million)
9.4. Early Cancer Screening
9.4.1. Early Cancer Screening Market, 2018 – 2030 (USD Million)
9.5. Recurrence Monitoring
9.5.1. Recurrence Monitoring Market, 2018 – 2030 (USD Million)
9.6. Others
9.6.1. Others Liquid Biopsy Market, 2018 – 2030 (USD Million)
Chapter 10. Product Business Analysis
10.1. Liquid Biopsy Market: Product Movement Analysis
10.2. Instruments
10.2.1. Instruments Market, 2018 – 2030 (USD Million)
10.3. Consumables Kits and Reagents
10.3.1. Consumables Kits and Reagents Market, 2018 – 2030 (USD Million)
10.4. Software and Services
10.4.1. Software and Services Market, 2018 – 2030 (USD Million)
Chapter 11. Regional Business Analysis
11.1. Liquid Biopsy Market Share By Region, 2023 & 2030
11.2. North America
11.2.1. North America Liquid biopsy market, 2018 – 2030 (USD Million)
11.2.2. U.S.
11.2.2.1. Key Country Dynamics
11.2.2.2. Target Disease Prevalence
11.2.2.3. Competitive Scenario
11.2.2.4. Regulatory Framework
11.2.2.5. Reimbursement Scenario
11.2.2.6. U.S. Liquid biopsy market, 2018 – 2030 (USD Million)
11.2.3. Canada
11.2.3.1. Key Country Dynamics
11.2.3.2. Target Disease Prevalence
11.2.3.3. Competitive Scenario
11.2.3.4. Regulatory Framework
11.2.3.5. Reimbursement Scenario
11.2.3.6. Canada Liquid biopsy market, 2018 – 2030 (USD Million)
11.3. Europe
11.3.1. Europe Liquid biopsy market, 2018 – 2030 (USD Million)
11.3.2. Germany
11.3.2.1. Key Country Dynamics
11.3.2.2. Target Disease Prevalence
11.3.2.3. Competitive Scenario
11.3.2.4. Regulatory Framework
11.3.2.5. Reimbursement Scenario
11.3.2.6. Germany Liquid biopsy market, 2018 – 2030 (USD Million)
11.3.3. UK
11.3.3.1. Key Country Dynamics
11.3.3.2. Target Disease Prevalence
11.3.3.3. Competitive Scenario
11.3.3.4. Regulatory Framework
11.3.3.5. Reimbursement Scenario
11.3.3.6. UK Liquid biopsy market, 2018 – 2030 (USD Million)
11.3.4. France
11.3.4.1. Key Country Dynamics
11.3.4.2. Target Disease Prevalence
11.3.4.3. Competitive Scenario
11.3.4.4. Regulatory Framework
11.3.4.5. Reimbursement Scenario
11.3.4.6. France Liquid biopsy market, 2018 – 2030 (USD Million)
11.3.5. Italy
11.3.5.1. Key Country Dynamics
11.3.5.2. Target Disease Prevalence
11.3.5.3. Competitive Scenario
11.3.5.4. Regulatory Framework
11.3.5.5. Reimbursement Scenario
11.3.5.6. Italy Liquid biopsy market, 2018 – 2030 (USD Million)
11.3.6. Spain
11.3.6.1. Key Country Dynamics
11.3.6.2. Target Disease Prevalence
11.3.6.3. Competitive Scenario
11.3.6.4. Regulatory Framework
11.3.6.5. Reimbursement Scenario
11.3.6.6. Spain Liquid biopsy market, 2018 – 2030 (USD Million)
11.3.7. Denmark
11.3.7.1. Key Country Dynamics
11.3.7.2. Target Disease Prevalence
11.3.7.3. Competitive Scenario
11.3.7.4. Regulatory Framework
11.3.7.5. Reimbursement Scenario
11.3.7.6. Denmark Liquid biopsy market, 2018 – 2030 (USD Million)
11.3.8. Sweden
11.3.8.1. Key Country Dynamics
11.3.8.2. Target Disease Prevalence
11.3.8.3. Competitive Scenario
11.3.8.4. Regulatory Framework
11.3.8.5. Reimbursement Scenario
11.3.8.6. Sweden Liquid biopsy market, 2018 – 2030 (USD Million)
11.3.9. Norway
11.3.9.1. Key Country Dynamics
11.3.9.2. Target Disease Prevalence
11.3.9.3. Competitive Scenario
11.3.9.4. Regulatory Framework
11.3.9.5. Reimbursement Scenario
11.3.9.6. Norway Liquid biopsy market, 2018 – 2030 (USD Million)
11.4. Asia Pacific
11.4.1. Asia Pacific Liquid biopsy market, 2018 – 2030 (USD Million)
11.4.2. Japan
11.4.2.1. Key Country Dynamics
11.4.2.2. Target Disease Prevalence
11.4.2.3. Competitive Scenario
11.4.2.4. Regulatory Framework
11.4.2.5. Reimbursement Scenario
11.4.2.6. Japan Liquid biopsy market, 2018 – 2030 (USD Million)
11.4.3. China
11.4.3.1. Key Country Dynamics
11.4.3.2. Target Disease Prevalence
11.4.3.3. Competitive Scenario
11.4.3.4. Regulatory Framework
11.4.3.5. Reimbursement Scenario
11.4.3.6. China Liquid biopsy market, 2018 – 2030 (USD Million)
11.4.4. India
11.4.4.1. Key Country Dynamics
11.4.4.2. Target Disease Prevalence
11.4.4.3. Competitive Scenario
11.4.4.4. Regulatory Framework
11.4.4.5. Reimbursement Scenario
11.4.4.6. India Liquid biopsy market, 2018 – 2030 (USD Million)
11.4.5. South Korea
11.4.5.1. Key Country Dynamics
11.4.5.2. Target Disease Prevalence
11.4.5.3. Competitive Scenario
11.4.5.4. Regulatory Framework
11.4.5.5. Reimbursement Scenario
11.4.5.6. South Korea Liquid biopsy market, 2018 – 2030 (USD Million)
11.4.6. Australia
11.4.6.1. Key Country Dynamics
11.4.6.2. Target Disease Prevalence
11.4.6.3. Competitive Scenario
11.4.6.4. Regulatory Framework
11.4.6.5. Reimbursement Scenario
11.4.6.6. Australia Liquid biopsy market, 2018 – 2030 (USD Million)
11.4.7. Thailand
11.4.7.1. Key Country Dynamics
11.4.7.2. Target Disease Prevalence
11.4.7.3. Competitive Scenario
11.4.7.4. Regulatory Framework
11.4.7.5. Reimbursement Scenario
11.4.7.6. Thailand Liquid biopsy market, 2018 – 2030 (USD Million)
11.5. Latin America
11.5.1. Latin America Liquid biopsy market, 2018 – 2030 (USD Million)
11.5.2. Brazil
11.5.2.1. Key Country Dynamics
11.5.2.2. Target Disease Prevalence
11.5.2.3. Competitive Scenario
11.5.2.4. Regulatory Framework
11.5.2.5. Reimbursement Scenario
11.5.2.6. Brazil Liquid biopsy market, 2018 – 2030 (USD Million)
11.5.3. Mexico
11.5.3.1. Key Country Dynamics
11.5.3.2. Target Disease Prevalence
11.5.3.3. Competitive Scenario
11.5.3.4. Regulatory Framework
11.5.3.5. Reimbursement Scenario
11.5.3.6. Mexico Liquid biopsy market, 2018 – 2030 (USD Million)
11.5.4. Argentina
11.5.4.1. Key Country Dynamics
11.5.4.2. Target Disease Prevalence
11.5.4.3. Competitive Scenario
11.5.4.4. Regulatory Framework
11.5.4.5. Reimbursement Scenario
11.5.4.6. Argentina Liquid biopsy market, 2018 – 2030 (USD Million)
11.6. MEA
11.6.1. MEA Liquid biopsy market, 2018 – 2030 (USD Million)
11.6.2. South Africa
11.6.2.1. Key Country Dynamics
11.6.2.2. Target Disease Prevalence
11.6.2.3. Competitive Scenario
11.6.2.4. Regulatory Framework
11.6.2.5. Reimbursement Scenario
11.6.2.6. South Africa Liquid biopsy market, 2018 – 2030 (USD Million)
11.6.3. Saudi Arabia
11.6.3.1. Key Country Dynamics
11.6.3.2. Target Disease Prevalence
11.6.3.3. Competitive Scenario
11.6.3.4. Regulatory Framework
11.6.3.5. Reimbursement Scenario
11.6.3.6. Saudi Arabia Liquid biopsy market, 2018 – 2030 (USD Million)
11.6.4. UAE
11.6.4.1. Key Country Dynamics
11.6.4.2. Target Disease Prevalence
11.6.4.3. Competitive Scenario
11.6.4.4. Regulatory Framework
11.6.4.5. Reimbursement Scenario
11.6.4.6. UAE Liquid biopsy market, 2018 – 2030 (USD Million)
11.6.5. Kuwait
11.6.5.1. Key Country Dynamics
11.6.5.2. Target Disease Prevalence
11.6.5.3. Competitive Scenario
11.6.5.4. Regulatory Framework
11.6.5.5. Reimbursement Scenario
11.6.5.6. Kuwait Liquid biopsy market, 2018 – 2030 (USD Million)
Chapter 12. Competitive Landscape
12.1. Participant’s overview
12.2. Financial performance
12.3. Participant categorization
12.3.1. Market Leaders
12.3.2. Liquid Biopsy Market Share Analysis, 2023
12.3.3. Company Profiles
12.3.3.1. ANGLE plc
12.3.3.1.1. Company Overview
12.3.3.1.2. Financial Performance
12.3.3.1.3. Product Benchmarking
12.3.3.1.4. Strategic Initiatives
12.3.3.2. Oncimmune Holdings PLC
12.3.3.2.1. Company Overview
12.3.3.2.2. Financial Performance
12.3.3.2.3. Product Benchmarking
12.3.3.2.4. Strategic Initiatives
12.3.3.3. Guardant Health
12.3.3.3.1. Company Overview
12.3.3.3.2. Financial Performance
12.3.3.3.3. Product Benchmarking
12.3.3.3.4. Strategic Initiatives
12.3.3.4. Myriad Genetics, Inc.
12.3.3.4.1. Company Overview
12.3.3.4.2. Financial Performance
12.3.3.4.3. Product Benchmarking
12.3.3.4.4. Strategic Initiatives
12.3.3.5. Biocept, Inc.
12.3.3.5.1. Company Overview
12.3.3.5.2. Financial Performance
12.3.3.5.3. Product Benchmarking
12.3.3.5.4. Strategic Initiatives
12.3.3.6. Lucence Health Inc.
12.3.3.6.1. Company Overview
12.3.3.6.2. Financial Performance
12.3.3.6.3. Product Benchmarking
12.3.3.6.4. Strategic Initiatives
12.3.3.7. Freenome Holdings, Inc.
12.3.3.7.1. Company Overview
12.3.3.7.2. Financial Performance
12.3.3.7.3. Product Benchmarking
12.3.3.7.4. Strategic Initiatives
12.3.3.8. F. Hoffmann-La Roche Ltd.
12.3.3.8.1. Company Overview
12.3.3.8.2. Financial Performance
12.3.3.8.3. Product Benchmarking
12.3.3.8.4. Strategic Initiatives
12.3.3.9. QIAGEN
12.3.3.9.1. Company Overview
12.3.3.9.2. Financial Performance
12.3.3.9.3. Product Benchmarking
12.3.3.9.4. Strategic Initiatives
12.3.3.10. Illumina, Inc.
12.3.3.10.1. Company Overview
12.3.3.10.2. Financial Performance
12.3.3.10.3. Product Benchmarking
12.3.3.10.4. Strategic Initiatives
12.3.3.11. Thermo Fisher Scientific, Inc.
12.3.3.11.1. Company Overview
12.3.3.11.2. Financial Performance
12.3.3.11.3. Product Benchmarking
12.3.3.11.4. Strategic Initiatives
12.3.3.12. Epigenomics AG
12.3.3.12.1. Company Overview
12.3.3.12.2. Financial Performance
12.3.3.12.3. Product Benchmarking
12.3.3.12.4. Strategic Initiatives
12.3.4. Strategy Mapping
12.3.4.1. Expansion
12.3.4.2. Acquisition
12.3.4.3. Collaborations
12.3.4.4. Disease Type/Drug Class Launch
12.3.4.5. Partnerships
12.3.4.6. Others

List of Tables

Table 1 List of Tables
Table 2 Global Liquid Biopsy Market, By Region, 2018 - 2030 (USD Million)
Table 3 Global Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 4 Global Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 5 Global Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 6 Global Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 7 Global Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 8 Global Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 9 Global Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 10 North America Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
Table 11 North America Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 12 North America Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 13 North America Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 14 North America Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 15 North America Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 16 North America Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 17 North America Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 18 U.S. Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 19 U.S. Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 20 U.S. Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 21 U.S. Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 22 U.S. Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 23 U.S. Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 24 U.S. Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 25 Canada Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 26 Canada Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 27 Canada Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 28 Canada Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 29 Canada Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 30 Canada Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 31 Canada Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 32 Europe Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
Table 33 Europe Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 34 Europe Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 35 Europe Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 36 Europe Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 37 Europe Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 38 Europe Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 39 Europe Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 40 UK Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 41 UK Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 42 UK Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 43 UK Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 44 UK Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 45 UK Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 46 UK Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 47 Germany Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 48 Germany Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 49 Germany Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 50 Germany Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 51 Germany Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 52 Germany Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 53 Germany Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 54 France Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 55 France Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 56 France Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 57 France Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 58 France Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 59 France Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 60 France Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 61 Italy Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 62 Italy Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 63 Italy Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 64 Italy Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 65 Italy Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 66 Italy Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 67 Italy Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 68 Spain Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 69 Spain Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 70 Spain Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 71 Spain Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 72 Spain Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 73 Spain Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 74 Spain Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 75 Denmark Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 76 Denmark Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 77 Denmark Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 78 Denmark Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 79 Denmark Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 80 Denmark Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 81 Denmark Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 82 Sweden Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 83 Sweden Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 84 Sweden Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 85 Sweden Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 86 Sweden Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 87 Sweden Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 88 Sweden Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 89 Norway Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 90 Norway Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 91 Norway Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 92 Norway Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 93 Norway Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 94 Norway Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 95 Norway Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 96 Asia Pacific Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
Table 97 Asia Pacific Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 98 Asia Pacific Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 99 Asia Pacific Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 100 Asia Pacific Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 101 Asia Pacific Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 102 Asia Pacific Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 103 Asia Pacific Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 104 Japan Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 105 Japan Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 106 Japan Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 107 Japan Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 108 Japan Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 109 Japan Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 110 Japan Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 111 China Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 112 China Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 113 China Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 114 China Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 115 China Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 116 China Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 117 China Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 118 India Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 119 India Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 120 India Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 121 India Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 122 India Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 123 India Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 124 India Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 125 Australia Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 126 Australia Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 127 Australia Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 128 Australia Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 129 Australia Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 130 Australia Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 131 Australia Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 132 South Korea Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 133 South Korea Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 134 South Korea Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 135 South Korea Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 136 South Korea Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 137 South Korea Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 138 South Korea Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 139 Thailand Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 140 Thailand Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 141 Thailand Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 142 Thailand Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 143 Thailand Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 144 Thailand Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 145 Thailand Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 146 Latin America Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
Table 147 Latin America Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 148 Latin America Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 149 Latin America Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 150 Latin America Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 151 Latin America Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 152 Latin America Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 153 Latin America Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 154 Brazil Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 155 Brazil Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 156 Brazil Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 157 Brazil Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 158 Brazil Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 159 Brazil Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 160 Brazil Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 161 Mexico Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 162 Mexico Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 163 Mexico Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 164 Mexico Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 165 Mexico Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 166 Mexico Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 167 Mexico Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 168 Argentina Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 169 Argentina Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 170 Argentina Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 171 Argentina Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 172 Argentina Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 173 Argentina Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 174 Argentina Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 175 Middle East & Africa Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
Table 176 Middle East & Africa Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 177 Middle East & Africa Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 178 Middle East & Africa Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 179 Middle East & Africa Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 180 Middle East & Africa Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 181 Middle East & Africa Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 182 Middle East & Africa Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 183 South Africa Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 184 South Africa Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 185 South Africa Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 186 South Africa Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 187 South Africa Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 188 South Africa Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 189 South Africa Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 190 Saudi Arabia Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 191 Saudi Arabia Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 192 Saudi Arabia Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 193 Saudi Arabia Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 194 Saudi Arabia Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 195 Saudi Arabia Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 196 Saudi Arabia Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 197 UAE Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 198 UAE Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 199 UAE Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 200 UAE Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 201 UAE Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 202 UAE Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 203 UAE Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
Table 204 Kuwait Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
Table 205 Kuwait Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
Table 206 Kuwait Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
Table 207 Kuwait Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
Table 208 Kuwait Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
Table 209 Kuwait Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
Table 210 Kuwait Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)

※본 조사보고서 [세계의 액체 생검 시장 (2024-2030) : 바이오마커별 (엑소좀, CTC), 용도별 (암, 생식기), 기술별, 샘플 유형별, 임상 용도별, 최종 용도별, 제품별, 지역별] (코드 : GRV24JNU066) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 액체 생검 시장 (2024-2030) : 바이오마커별 (엑소좀, CTC), 용도별 (암, 생식기), 기술별, 샘플 유형별, 임상 용도별, 최종 용도별, 제품별, 지역별] 에 대해서 E메일 문의는 여기를 클릭하세요.

*** 아래는 관련 보고서 소개입니다 ***

세계의 천식 치료제 시장 (2023-2030) : 약물 종류별 (항염증제, 병용 요법), 제품별 (흡입기, 분무기), 투여 경로별, 지역별
GRV23NOV046 / Grand View Research / 2023년 9월 / 글로벌 천식 치료제 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 천식 치료제 시장 규모는 2023년부터 2030년까지 연평균 4. 3%의 성장률을 보이며 2030년 332억 달러에 달할 것으로 예측됩니다....Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 세계의 천식 치료제 시장 변수/동향/범위 Chapter 4. 세계의 천식 치료제 시장 : 약품 종류별 예측 및 동향 분석 Chapter 5. 세계의 천식 치료제 시장 : 제품별 예측 및 동향 분석 Chapter 6. 세계의 천식 치료제 시장 : 투여 경로별...

세계의 ADME 독성 검사 시장 (2023-2030) : 기술별 (세포 배양, OMICS Tech), 용도별 (신경 독성, 신장 독성), 방법별 (세포 분석, In-Silica)
GRV23NOV027 / Grand View Research / 2023년 9월 / 글로벌 ADME 독성 검사 시장의 성장 및 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 ADME 독성 검사 시장 규모는 2030년까지 1921억 달러의 수익을 창출하고 예측 기간 동안 10. 2%의...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 세계의 ADME 독성 검사 시장 변수/동향/범위 Chapter 4. 세계의 ADME 독성 검사 시장 : 기술별 예측 및 동향 분석 Chapter 5. 세계의 ADME 독성 검사 시장 : 용도별 예측 및 동향 분석 Chapter 6. 세계의 ADME 독성 검사 시장...

세계의 중환자 치료 진단 시장 (2023-2030) : 유형별 (유세포 분석, 혈액학), 최종 용도별 (수술실, 응급실, 중환자실), 지역별
GRV23NOV086 / Grand View Research / 2023년 9월 / 글로벌 중환자 치료 진단 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 중환자 치료 진단 시장 규모는 2030년까지 17. 2억 달러에 달할 것으로 예상되며, 2023년부터 2030년까지 연평균 4....Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 세계의 중환자 치료 진단 시장 변수/동향/범위 Chapter 4. 세계의 중환자 치료 진단 시장 : 유형별 예측 및 동향 분석 Chapter 5. 세계의 중환자 치료 진단 시장 : 최종 용도별 예측 및 동향 분석 Chapter 6. 세계의 중환자 치료 진단...

세계의 희귀 바이오 마커 검체 채취 및 안정화 시장 (2023-2030) : 바이오마커별, 최종 용도별 (연구, 진단), 지역별
GRV23NOV163 / Grand View Research / 2023년 9월 / 글로벌 희귀 바이오 마커 검체 채취 및 안정화 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 희귀 바이오 마커 검체 채취 및 안정화 시장 규모는 2030년까지 841억8000만 달러에...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변동, 동향, 범위 Chapter 4. 세계의 희귀 바이오 마커 검체 채취 및 안정화 시장 : 바이오마커별 예측 및 동향 분석 Chapter 5. 세계의 희귀 바이오 마커 검체 채취 및 안정화 시장 : 최종 용도별 예측 및 동향 분석...

세계의 의료 영상 시장 2024-2030 : 기술별 (엑스레이, 컴퓨터 단층 촬영 (CT), 초음파, 핵의학 영상), 용도별, 최종 용도별, 지역별
GRV24MAY121 / Grand View Research / 2024년 4월 / 글로벌 의료 영상 시장의 성장과 동향 Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 의료 영상 시장 규모는 2030년까지 554억 달러에 달할 것으로 예상되며, 2024년부터 2030년까지 연평균 4. 9%의 성장률로...1. 조사 방법 및 범위 2. 개요 3. 시장의 변수, 동향, 범위 4. 세계의 의료 영상 시장 기술별 예측 및 동향 분석 5. 세계의 의료 영상 시장 용도별 예측 및 동향 분석 6. 세계의 의료 영상 시장 최종 용도별 예측 및 동향 분석 7. 세계의 의료 영상 시장 지역별 예측...

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!